AgeX Therapeutics Reports First Quarter 2023 Financial Results

ALAMEDA, Calif.--(BUSINESS WIRE)--AgeX Therapeutics, Inc. (“AgeX”; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, reported its financial and operating results for quarter ended March 31, 2023.Balance Sheet InformationCash, cash equivalents, and restricted cash...

Related Keywords

Alabama ,United States ,American , ,Agex Therapeutics Inc ,Twitter ,Facebook ,Linkedin ,Exchange Commission ,Serina Therapeutics Inc ,Youtube ,Agex Therapeutics ,Juvenescence Limited ,Secured Note Line ,Restated Secured Convertible Promissory Note ,Secured Note ,Total Revenues ,Accounting Standards Update ,Financial Statements Going Concern ,Quarterly Report ,Private Securities Litigation Reform Act ,Annual Report ,